These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35214612)

  • 1. Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose.
    Đaković Rode O; Bodulić K; Zember S; Cetinić Balent N; Novokmet A; Čulo M; Rašić Ž; Mikulić R; Markotić A
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination.
    Zember S; Bodulić K; Balent NC; Mikulić R; Markotić A; Đaković Rode O
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survey of spike-specific immunoglobulin G antibodies at approximately 3 months and 9 months after vaccination against coronavirus disease 2019 (severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2]) in health care workers].
    Miyajima E; Imaizumi H; Oshida S; Igarashi K; Yoshida M; Yanase N
    Sangyo Eiseigaku Zasshi; 2023 Jan; 65(1):18-27. PubMed ID: 35314567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.
    Bansal D; Atia H; Al Badr M; Nour M; Abdulmajeed J; Hasan A; Al-Hajri N; Ahmed L; Ibrahim R; Zamel R; Mohamed A; Pattalaparambil H; Daraan F; Chaudhry A; Oraby S; El-Saleh S; El-Shafie SS; Al-Farsi AF; Paul J; Ismail A; Al-Romaihi HE; Al-Thani MH; Doi SAR; Zughaier SM; Cyprian F; Farag E; Farooqui HH
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination.
    Lippi G; Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi G
    Adv Lab Med; 2022 Mar; 3(1):39-50. PubMed ID: 37359438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Dynamics of SARS-CoV-2 IgG Antibody Responses after the Two-Dose Regimen of BNT162b2 Vaccination and the Effect of a Third Dose on Healthcare Workers in Japan.
    Sakamoto A; Yoshimura M; Itoh R; Ozuru R; Ishii K; Sechi Y; Nabeshima S; Hiromatsu K
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study.
    Buonfrate D; Piubelli C; Gobbi F; Martini D; Bertoli G; Ursini T; Moro L; Ronzoni N; Angheben A; Rodari P; Cardellino C; Tamarozzi F; Tais S; Rizzi E; Degani M; Deiana M; Prato M; Silva R; Bisoffi Z
    Clin Microbiol Infect; 2021 Dec; 27(12):1845-1850. PubMed ID: 34329793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection.
    Israel A; Shenhar Y; Green I; Merzon E; Golan-Cohen A; Schäffer AA; Ruppin E; Vinker S; Magen E
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine.
    Ferrari L; Compagno M; Campogiani L; Teti E; Mulas T; Checchi D; Alessio G; Caldara F; Coppola L; De Simone G; Ceccarelli L; Spalliera I; Vitale P; Grelli S; Andreoni M; Sarmati L; Iannetta M
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers.
    Vassilaki N; Gargalionis AN; Bletsa A; Papamichalopoulos N; Kontou E; Gkika M; Patas K; Theodoridis D; Manolis I; Ioannidis A; Milona RS; Tsirogianni A; Angelakis E; Chatzipanagiotou S
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults.
    Erice A; Varillas-Delgado D; Caballero C
    Clin Microbiol Infect; 2022 Jan; 28(1):139.e1-139.e4. PubMed ID: 34508885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
    Olariu TR; Ursoniu S; Marincu I; Lupu MA
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel.
    Shachor-Meyouhas Y; Hussein K; Dabaja-Younis H; Szwarcwort-Cohen M; Almog R; Weissman A; Mekel M; Hyams G; Horowitz NA; Gepstein V; Netzer I; Saban HC; Petersiel N; Tarabeia J; Halberthal M
    Clin Microbiol Infect; 2022 Mar; 28(3):450.e1-450.e4. PubMed ID: 34838782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers.
    Mochizuki T; Hori T; Yano K; Ikari K; Okazaki K
    Clin Exp Vaccine Res; 2023 Apr; 12(2):116-120. PubMed ID: 37214144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection.
    Israel A; Shenhar Y; Green I; Merzon E; Golan-Cohen A; Schäffer AA; Ruppin E; Vinker S; Magen E
    medRxiv; 2021 Aug; ():. PubMed ID: 34462761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients.
    Hirai K; Shimotashiro M; Okumura T; Ookawara S; Morishita Y
    Kidney Res Clin Pract; 2024 May; 43(3):326-336. PubMed ID: 38389151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers.
    Nakai M; Yokoyama D; Sato T; Sato R; Kojima C; Shimosawa T
    Heliyon; 2023 Jun; 9(6):e16547. PubMed ID: 37235203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.